Whalesbook
IPO ke paise kahan jayenge?
Pramodini Medicare NSE Emerge par list hone wala hai aur iske through 58.51 lakh shares offer kar rahe hain. Ismein se 53.5 lakh naye shares hain aur 5 lakh promoter bech rahe hain. Total ₹45.1 crore ka fund raise hoga, jiska maximum amount new medical equipment khareedne mein lagega. Kuch funds general corporate needs aur potential acquisitions mein bhi jayenge. Matlab ekdum solid expansion plan hai!
Company ka Business Model?
Yeh company desh bhar mein 6 states mein apne 15 diagnostic centres operate karti hai. Yeh radiology, clinical lab aur nuclear medicine services provide karte hain. Inka business model cool hai, public-private partnerships (PPP), Public Sector Undertakings (PSUs) ke saath alliances, aur standalone centres par depend karta hai. Isse alag-alag jagah se income aati rahegi.
Financials kaise hain?
Company ne financial growth achhi dikhai hai. December 2025 tak ke 9 mahino mein, ₹44.4 crore ki revenue par ₹12.5 crore ka profit report kiya. Pichhle saal March 2025 mein, profit 74.3% badhkar ₹10.04 crore ho gaya tha, jabki revenue 8.5% badhkar ₹38.2 crore hui thi. Growth toh hai, ab dekhte hain scale karne par kaise perform karte hain.
Market Mein Competition?
India ka diagnostics sector tezi se badh raha hai, aur FY2030 tak yeh $37 billion ka ho jayega, matlab saal mein 11.7% growth rate. Lekin market kafi fragmented hai, bade players ka hi zyada kabza hai. Pramodini ko Krsnaa Diagnostics jaise badi companies se takkar leni padegi, jinka market value lagbhag ₹1,957 crore hai aur 1,800+ centres hain. Invicta Diagnostic aur Star Imaging & Path Labs bhi competitors hain.
Growth ke Factors Aur Risks?
Is sector mein growth ke liye chronic diseases ka badhna, health awareness aur government ka preventive care par focus bhej hai. AI aur genomics jaise tech bhi naye opportunities laa rahe hain. Pramodini ka partnership model acha hai kyunki woh existing infrastructure use karte hain, jisse cost kam hoti hai. Lekin sabse bada risk hai execution. IPO se jo paisa raise hoga, use sahi tarah se use karna aur acquisitions ko manage karna challenge hoga. Partnership models mein bhi risks hain, jaise contract renegotiations aur government spending mein changes.